Adenosine A2A receptors activation facilitates neuromuscular transmission in the pre-symptomatic phase of the SOD1(G93A) ALS mice, but Not in the symptomatic phase

PLoS ONE

Volumn 9, Issue 8, 2014, Pages

  Nascimento, Filipe ^a,b   Pousinha, Paula A ^a,b,e   Correia, Alexandra M ^b,c,f   Gomes, Rui ^b,d   Sebastião, Ana M ^a,b   Ribeiro, Joaquim A ^a,b  

^a INSTITUTO DE MEDICINA MOLECULAR   (Portugal)

^b UNIVERSITY OF LISBON   (Portugal)

^c Museu Nacional de Historia Natural Universidade de Lisboa   (Portugal)

^d UNIVERSITY OF LISBON   (Portugal)

^e INSTITUT DE PHARMACOLOGIE MOLÉCULAIRE ET CELLULAIRE   (France)

^f PRINCETON UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A2A RECEPTOR; COPPER ZINC SUPEROXIDE DISMUTASE; 2-(4-(2-CARBOXYETHYL)PHENETHYLAMINO)-5'-N-ETHYLCARBOXAMIDOADENOSINE; ADENOSINE; PHENETHYLAMINE DERIVATIVE; SUPEROXIDE DISMUTASE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; ASYMPTOMATIC DISEASE; BRAIN ELECTROPHYSIOLOGY; CALCIUM CELL LEVEL; CONTROLLED STUDY; DISEASE COURSE; ENDPLATE POTENTIAL; EXCITATORY JUNCTION POTENTIAL; FEMALE; HEMIDIAPHRAGM; MALE; MEMBRANE STEADY POTENTIAL; MINIATURE ENDPLATE POTENTIAL; MOTONEURON; MOUSE; NERVE CELL MEMBRANE STEADY POTENTIAL; NEUROMODULATION; NEUROMUSCULAR FUNCTION; NEUROMUSCULAR TRANSMISSION; NONHUMAN; PHRENIC NERVE; POINT MUTATION; POLYMERASE CHAIN REACTION; PROTEIN FUNCTION; ANALOGS AND DERIVATIVES; ANIMAL; DRUG EFFECTS; EXCITATORY POSTSYNAPTIC POTENTIAL; GENETICS; HUMAN; METABOLISM; MUTATION; NERVE ENDING; NEUROMUSCULAR SYNAPSE; PATHOLOGY; PATHOPHYSIOLOGY; SYNAPTIC TRANSMISSION; TRANSGENIC MOUSE;

ADENOSINE; AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; DISEASE PROGRESSION; EXCITATORY POSTSYNAPTIC POTENTIALS; HUMANS; MALE; MICE, TRANSGENIC; MOTOR ENDPLATE; MUTATION; NEUROMUSCULAR JUNCTION; PHENETHYLAMINES; RECEPTOR, ADENOSINE A2A; SUPEROXIDE DISMUTASE; SYNAPTIC TRANSMISSION;

EID: 84905497633     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0104081     Document Type: Article

References (51)

1. Turner MR, Hardiman O, Benatar M, Brooks BR, Chio A, et al. (2013) Controversies and priorities in amyotrophic lateral sclerosis. Lancet Neurol 12: 310-22.
2. Robberecht W, Philips T (2013) The changing scene of amyotrophic lateral sclerosis. Nat Rev Neurosci 14: 248-64.
3. Rosen DR, Siddique T, Patterson D, Figlewicz DA, Sapp P, et al. (1993) Mutations in Cu/Zn superoxide dismutase gene are associated with familial amyotrophic lateral sclerosis. Nature 364: 362. (Pubitemid 23265284)
4. Gurney ME, Pu H, Chiu AY, Dal Canto MC, Polchow CY, et al. (1994) Motor neuron degeneration in mice that express a human Cu, Zn superoxide dismutase mutation. Science 264: 1772-5. (Pubitemid 24227760)
5. Kim YI, Joo C, Cheng CC, Davis CE, O'Shaughnessy TJ (1997) Neuromuscular transmission in a transgenic animal model of motor neuron disease. Proceedings of the 18th Annual International Conference of the Ieee Engineering in Medicine and Biology Society, Vol 18, Pts 1-5 18: 1773-1774.
6. Naumenko N, Pollari E, Kurronen A, Giniatullina R, Shakirzyanova A, et al. (2011) Gender-specific mechanism of synaptic impairment and its prevention by GCSF in a mouse model of ALS. Frontiers in Cellular Neuroscience 5.
7. Rocha MC, Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA (2013) Early Changes of Neuromuscular Transmission in the SOD1(G93A) Mice Model of ALS Start Long before Motor Symptoms Onset. PLoS One 8: e73846.
8. Sebastião AM, Ribeiro JA (2009) Adenosine receptors and the central nervous system. Handb Exp Pharmacol 471-534.
9. Correia-de-Sá P, Sebastião AM, Ribeiro JA (1991) Inhibitory and excitatory effects of adenosine receptor agonists on evoked transmitter release from phrenic nerve ending of the rat. Br J Pharmacol 103: 1614-20.
10. Beghi E, Pupillo E, Messina P, Giussani G, Chio A, et al. (2011) Coffee and amyotrophic lateral sclerosis: a possible preventive role. Am J Epidemiol 174: 1002-8.
11. Potenza RL, Armida M, Ferrante A, Pezzola A, Matteucci A, et al. (2013) Effects of chronic caffeine intake in a mouse model of amyotrophic lateral sclerosis. J Neurosci Res 91: 585-92.
12. Yanpallewar SU, Barrick CA, Buckley H, Becker J, Tessarollo L (2012) Deletion of the BDNF truncated receptor TrkB. T1 delays disease onset in a mouse model of amyotrophic lateral sclerosis. PLoS One 7: e39946.
13. Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA (2010) Predominance of adenosine excitatory over inhibitory effects on transmission at the neuromuscular junction of infant rats. J Pharmacol Exp Ther 332: 153-63.
14. Ribeiro JA, Sebastião AM (1987) On the role, inactivation and origin of endogenous adenosine at the frog neuromuscular junction. J Physiol 384: 571-85.
15. Ribeiro JA, Walker J (1975) The effects of adenosine triphosphate and adenosine diphosphate on transmission at the rat and frog neuromuscular junctions. Br J Pharmacol 54: 213-8.
16. Krebs HA, Henseleit K (1932) Untersuchungen uber die Harnstoffbildung im Tierkoper. Hoppe-Seyler's Z Physiol Chem 210: 33-37.
17. Jarvis MF, Schulz R, Hutchison AJ, Do UH, Sills MA, et al. (1989) [H-3] Cgs-21680, a Selective A2 Adenosine Receptor Agonist Directly Labels A2-Receptors in Rat-Brain. Journal of Pharmacology and Experimental Therapeutics 251: 888-893. (Pubitemid 20024901)
18. Pousinha PA, Correia AM, Sebastião AM, Ribeiro JA (2012) Neuromuscular transmission modulation by adenosine upon aging. Neurobiol Aging 33: 2869-80.
19. 2A adenosine receptor agonist CGS-21680 on spontaneous and K+-evoked acetylcholine release at the mouse neuromuscular junction. Neuroscience 172: 164-76.
20. 2A receptor antagonist, is a useful ligand in autoradiographic studies. J Neurochem 70: 1210-6.
21. Sellin L, Molgo J, Tornquist K, Hansson B, Thesleff S (1996) On the possible origin of giant or slow-rising miniature end-plate potentials at the neuromuscular junction. Pflugers Arch 431: 325-34.
22. Weinstein SP (1980) A comparative electrophysiological study of motor endplate diseased skeletal muscle in the mouse. J Physiol 307: 453-64.
23. Correia-de-Sá P, Timóteo MA, Ribeiro JA (2000) A(2A) adenosine receptor facilitation of neuromuscular transmission: influence of stimulus paradigm on calcium mobilization. J Neurochem 74: 2462-9. (Pubitemid 30314222)
24. Oliveira L, Timóteo MA, Correia-de-Sá P (2004) Tetanic depression is overcome by tonic adenosine A(2A) receptor facilitation of L-type Ca(2 +) influx into rat motor nerve terminals. J Physiol 560: 157-68. (Pubitemid 39406023)
25. 2A receptors in the limbic cortex, but not striatum, of aged rats. J Neurochem 73: 1733-8.
26. 2a-adenosine receptor of the rat motor nerve endings is positively coupled to adenylate cyclase. Naunyn Schmiedebergs Arch Pharmacol 350: 514-22.
27. 2A facilitatory adenosine receptor activation balance depends on motor nerve stimulation paradigm at the rat hemidiaphragm. J Neurophysiol 76: 3910-9.
28. 2A receptor activation modulates nicotinic autoreceptor function at the rat neuromuscular junction. Eur J Pharmacol 271: 349-55.
29. Pousinha PA, Diogenes MJ, Ribeiro JA, Sebastião AM (2006) Triggering of BDNF facilitatory action on neuromuscular transmission by adenosine A2A receptors. Neurosci Lett 404: 143-7. (Pubitemid 44041789)
30. 2a-adenosine receptor activation of CGRP-facilitated [3H]-ACh release from rat motor nerve endings. Br J Pharmacol 111: 582-8.
31. Tsentsevitsky A, Kovyazina I, Nikolsky E, Bukharaeva E, Giniatullin R (2013) Redox-sensitive synchronizing action of adenosine on transmitter release at the neuromuscular junction. Neuroscience 248: 699-707.
32. Kust BM, Copray JC, Brouwer N, Troost D, Boddeke HW (2002) Elevated levels of neurotrophins in human biceps brachii tissue of amyotrophic lateral sclerosis. Exp Neurol 177: 419-27. (Pubitemid 35366131)
33. Boulanger LM, Poo MM (1999) Presynaptic depolarization facilitates neurotrophin-induced synaptic potentiation. Nat Neurosci 2: 346-51.
34. Mantilla CB, Zhan WZ, Sieck GC (2004) Neurotrophins improve neuromuscular transmission in the adult rat diaphragm. Muscle Nerve 29: 381-6. (Pubitemid 38269757)
35. Huang EJ, Reichardt LF (2001) Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci 24: 677-736. (Pubitemid 32695243)
36. Belluardo N, Westerblad H, Mudo G, Casabona A, Bruton J, et al. (2001) Neuromuscular junction disassembly and muscle fatigue in mice lacking neurotrophin-4. Mol Cell Neurosci 18: 56-67. (Pubitemid 32695192)
37. Gonzalez M, Ruggiero FP, Chang Q, Shi YJ, Rich MM, et al. (1999) Disruption of Trkb-mediated signaling induces disassembly of postsynaptic receptor clusters at neuromuscular junctions. Neuron 24: 567-83.
38. Norris FH Jr, Gasteiger EL (1955) Action potentials of single motor units in normal muscle. Electroencephalogr Clin Neurophysiol 7: 115-25.
39. Catterall WA, Few AP (2008) Calcium channel regulation and presynaptic plasticity. Neuron 59: 882-901.
40. 2+ uptake deficit in disease endstage vulnerable motoneurons of the SOD1G93A mouse model of amyotrophic lateral sclerosis. J Physiol 591: 2723-45.
41. Ribeiro JA, Cunha RA, Correia-de-Sá P, Sebastião AM (1996) Purinergic regulation of acetylcholine release. Prog Brain Res 109: 231-41. (Pubitemid 27047093)
42. Noronha-Matos JB, Morais T, Trigo D, Timóteo MA, Magalhães-Cardoso MT, et al. (2011) Tetanic failure due to decreased endogenous adenosine A(2A) tonus operating neuronal Ca(v) 1 (L-type) influx in Myasthenia gravis. J Neurochem 117: 797-811.
43. Hu JH, Zhang H, Wagey R, Krieger C, Pelech SL (2003) Protein kinase and protein phosphatase expression in amyotrophic lateral sclerosis spinal cord. J Neurochem 85: 432-42. (Pubitemid 36438338)
44. Uchitel OD, Appel SH, Crawford F, Sczcupak L (1988) Immunoglobulins from amyotrophic lateral sclerosis patients enhance spontaneous transmitter release from motor-nerve terminals. Proc Natl Acad Sci U S A 85: 7371-4.
45. Fratantoni SA, Weisz G, Pardal AM, Reisin RC, Uchitel OD (2000) Amyotrophic lateral sclerosis IgG-treated neuromuscular junctions develop sensitivity to L-type calcium channel blocker. Muscle Nerve 23: 543-50. (Pubitemid 30164780)
46. Phani S, Re DB, Przedborski S (2012) The Role of the Innate Immune System in ALS. Front Pharmacol 3: 150.
47. Hasko G, Linden J, Cronstein B, Pacher P (2008) Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7: 759-70.
48. 2A receptor attenuates experimental autoimmune myasthenia gravis severity. Eur J Immunol 42: 1140-51.
49. Todd KJ, Robitaille R (2006) Purinergic modulation of synaptic signalling at the neuromuscular junction. Pflugers Arch 452: 608-14. (Pubitemid 44015095)
50. Ydens E, Lornet G, Smits V, Goethals S, Timmerman V, et al. (2013) The neuroinflammatory role of Schwann cells in disease. Neurobiol Dis 55: 95-103.
51. 2A adenosine receptors are up-regulated in lymphocytes from amyotrophic lateral sclerosis patients. Amyotroph Lateral Scler Frontotemporal Degener 14: 406-13.